| Autor: |
Lui RNS; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China., Mak LLY; Division of Gastroenterology and Hepatology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China., Kung KN; Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong SAR, China., Leung CM; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China., Li RST; Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong SAR, China., Ma YK; Department of Medicine, Tuen Mun Hospital, Hong Kong SAR, China., Ng CKM; Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong SAR, China., Chan HLY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Union Hospital, Hong Kong SAR, China., Yuen MF; Division of Gastroenterology and Hepatology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China., Wong GLH; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China., Fung J; Division of Gastroenterology and Hepatology, Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China. |
| Abstrakt: |
Competing Interests: RNS Lui has served as an advisory board member for Gilead Sciences and speaker for GenieBiome; he also holds equity in Pfizer. As an editor of the journal, RNS Lui was not involved in the peer review process. LLY Mak has served as a speaker for Roche. HLY Chan is an advisor for Aligos, GlaxoSmithKline, Roche, Vaccitech, and Virion Therapeutics; a speaker for Echosens, Gilead Sciences, Roche, and Viatris; and a data management board member for Aligos, Arbutus, Roche, Vaccitech, and Zhimeng Therapeutics. MF Yuen has served as an advisor/consultant for and/or received grant/research support from AbbVie, Aligos, AiCuris, Antios Therapeutics, Arbutus Biopharma, Arrowhead Pharmaceuticals, Assembly Biosciences, Bristol Myers Squibb, ClearB Therapeutics, Dicerna Pharmaceuticals, Finch Therapeutics, Fujirebio, GlaxoSmithKline, Gilead Sciences, Immunocore, Janssen, Roche, Silverback Therapeutics, Sysmex Corporation, Tune Therapeutics, Vir Biotechnology, and Visirna Therapeutics. GLH Wong has served as an advisory board member for AstraZeneca, Gilead Sciences, and Janssen, as well as a speaker for Abbott, AbbVie, Ascletis, Bristol Myers Squibb, Echosens, Gilead Sciences, Janssen, and Roche; she has also received a research grant from Gilead Sciences. Other authors have disclosed no conflicts of interest. |
